Skip to content
The Nexus
DossierENTITY

KRAS-driven lung cancer

Coverage of KRAS-driven lung cancer in the Nexus archive.

Earliest in view: Jul 2 · 14:13 UTCMost recent: Jul 2 · 14:13 UTC
Co-mentioned in this coverage
Rocheorganization1STAT+organization1FDAorganization1Democratsorganization1
Recent coverage
  • HEALTHJul 2 · 14:13 UTCSTAT NEWS
    STAT+: Roche drug sets new standard for KRAS-driven lung cancer

    Roche's drug establishes a new standard for treating KRAS-driven lung cancer. The article is part of a biotech newsletter discussing recent developments in the sector, including FDA regulatory updates and political changes affecting biopharma policy.